DONATE

Manuel Salmerón

IBEC showcases cutting-edge biomedical innovation at the Health Revolution Congress 2026

The Institute for Bioengineering of Catalonia brought together researchers, investors and industry leaders with its event “IBEC Health Revolution Day: Engineering the Future of Medicine”, as part of the Health Revolution Congress. Through expert panels, technology pitches and scientific talks, the event showcased cutting-edge biomedical technologies and discussed how to translate scientific discoveries into real-world healthcare solutions.

IBEC makes its mark at TERMISEU 2026 with a strong scientific presence and a key role in the conference’s leadership

From 21 to 24 April 2026, IBEC had a significant presence at TERMISEU 2026, the leading European conference on tissue engineering and regenerative medicine. Held at the Palma Conference Centre in Mallorca, the event brought together more than 1,600 researchers.

Barcelona hosts the fourth edition of the EMBL-IBEC Conference

The fourth EMBL-IBEC Conference, organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL), focused on disease modelling, developmental biology, and regenerative medicine. The event brought around 130 international bioengineering experts together at the PRBB in Barcelona this week.

IBEC welcomes a new international cohort of doctoral students in collaboration with hospitals and centres of excellence

The Institute for Bioengineering of Catalonia (IBEC) is pleased to welcome new international students to its PhD programme. This initiative offers excellent training and research opportunities in bioengineering, as well as strong collaboration with leading hospitals and institutions.

Amayra Hernández-Vega receives a grant from the Pasqual Maragall Foundation to advance research on the early stages of Alzheimer’s

IBEC researcher Amayra Hernández-Vega has been awarded a grant from the Pasqual Maragall Researchers Programme to lead a project focused on studying the earliest stages of Alzheimer’s disease. The study will combine in vitro and human models of familial Alzheimer’s disease to identify age-related factors and potential inhibitors that could slow the early progression of the disease. The project was presented at an informative session on sleep and brain health, which was attended by around 500 people.

Josep Samitier concludes thirteen years at the helm of IBEC

Josep Samitier will step down as Director of the Institute for Bioengineering of Catalonia (IBEC) on 31 December 2025. Under his leadership since 2013, IBEC has become a leading institution in Spain for research excellence in bioengineering. Manuel Salmeron, an ICREA Research Professor at IBEC, will take over as interim director at the request of the Institute’s board of trustees.

The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

IBEC and SEMIT host the first SEMIT Congress in Barcelona

The Institute for Bioengineering of Catalonia (IBEC) and the Spanish Society of Regenerative Medicine and Tissue Engineering (SEMIT) organized the inaugural SEMIT 2025 Congress. The event gathered leading national and international experts in regenerative medicine and tissue engineering, creating a unique platform for knowledge exchange among researchers, clinicians, and industry.

IBEC and EMBL Barcelona co-organise a matchmaking workshop to explore synergies

Today, the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) held a matchmaking workshop. The event brought together leading researchers from both centres to encourage the formation of new connections and promote scientific dialogue.

Two IBEC projects receive ERC funding to advance bioinks for 3D printing and cancer therapies

Manuel Salmeron and Xavier Rovira, who are both principal investigators at IBEC, have each been awarded an ERC Proof of Concept Grant. These prestigious grants are awarded by the European Research Council to explore the commercial and social potential of research projects carried out at European institutions. Salmeron’s project, FACTORINK, focuses on designing functional bioinks with biological activity for printing artificial tissues. Meanwhile, Rovira’s project seeks to develop the EVOaware platform, which is designed to address tumour resistance to therapies and accelerate the discovery and development of new cancer treatments.